[go: up one dir, main page]

ZA974334B - Fluorinated Vitamin D3 analogs. - Google Patents

Fluorinated Vitamin D3 analogs.

Info

Publication number
ZA974334B
ZA974334B ZA9704334A ZA974334A ZA974334B ZA 974334 B ZA974334 B ZA 974334B ZA 9704334 A ZA9704334 A ZA 9704334A ZA 974334 A ZA974334 A ZA 974334A ZA 974334 B ZA974334 B ZA 974334B
Authority
ZA
South Africa
Prior art keywords
analogs
fluorinated vitamin
fluorinated
vitamin
Prior art date
Application number
ZA9704334A
Other languages
English (en)
Inventor
Bernard Michael Hennessy
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA974334B publication Critical patent/ZA974334B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9704334A 1996-05-23 1997-05-19 Fluorinated Vitamin D3 analogs. ZA974334B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1818796P 1996-05-23 1996-05-23

Publications (1)

Publication Number Publication Date
ZA974334B true ZA974334B (en) 1997-11-24

Family

ID=21786696

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704334A ZA974334B (en) 1996-05-23 1997-05-19 Fluorinated Vitamin D3 analogs.

Country Status (30)

Country Link
US (1) US5888994A (xx)
EP (1) EP0808831B1 (xx)
JP (1) JP2858571B2 (xx)
KR (1) KR100237523B1 (xx)
CN (1) CN1081184C (xx)
AR (1) AR007240A1 (xx)
AT (1) ATE195514T1 (xx)
AU (1) AU720098B2 (xx)
BR (1) BR9703373A (xx)
CA (1) CA2204478C (xx)
CO (1) CO4840512A1 (xx)
CZ (1) CZ157997A3 (xx)
DE (1) DE69702812T2 (xx)
DK (1) DK0808831T3 (xx)
ES (1) ES2150719T3 (xx)
GR (1) GR3034832T3 (xx)
HR (1) HRP970274A2 (xx)
HU (1) HUP9700927A3 (xx)
IL (1) IL120842A0 (xx)
MA (1) MA24345A1 (xx)
NO (1) NO971934L (xx)
NZ (1) NZ314838A (xx)
PL (1) PL320131A1 (xx)
PT (1) PT808831E (xx)
SG (1) SG50831A1 (xx)
TR (1) TR199700418A2 (xx)
TW (1) TW374762B (xx)
UY (1) UY24563A1 (xx)
YU (1) YU19997A (xx)
ZA (1) ZA974334B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
CA2289209C (en) * 1997-05-16 2006-07-25 Women & Infants Hospital Cyclic ether vitamin d3 compounds, 1.alpha. (oh) 3-epi-vitamin d3 compounds and uses thereof
US6017908A (en) * 1997-05-16 2000-01-25 Women And Infants Hospital 3-EPI vitamin D2 compounds and uses thereof
AU1022999A (en) * 1997-09-08 1999-03-29 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
AU3390400A (en) * 1999-03-05 2000-09-21 Johns Hopkins University, The Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
DK1993559T3 (en) 2006-02-03 2016-10-03 Opko Renal Llc Treatment of vitamin D deficiency and MALFUNCTION with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
SI2679228T1 (en) 2006-06-21 2018-06-29 Opko Ireland Global Holdings, Ltd. THERAPY WITH THE USE OF VITAMIN D ADDITIONAL FIBER AND HORMON RESISTANCE OF VITAMIN D
DK2148684T3 (da) 2007-04-25 2013-04-22 Cytochroma Inc Fremgangsmåde til behandling af vitamin D-insufficiens og -deficiens
SI2148661T1 (sl) 2007-04-25 2013-04-30 Cytochroma Inc. Nadzorovano oralno sproščanje sestavkov, ki vsebujejo spojino vitamina D in voskasti naosilec
RS60087B1 (sr) 2010-03-29 2020-05-29 Opko Ireland Global Holdings Ltd Postupci i kompozicije za snižavanje nivoa paratireoidnog hormona
WO2012065050A1 (en) 2010-11-12 2012-05-18 Wisconsin Alumni Research Foundation 22-haloacetoxy-homopregnacalciferol analogs and their uses
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 d 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US11173168B2 (en) 2016-03-28 2021-11-16 Eirgen Pharma Ltd. Methods of treating vitamin D insufficiency in chronic kidney disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039671A (en) * 1984-12-19 1991-08-13 Hoffmann-La Roche Inc. Trifluorinated-1α,25S-dihydroxy vitamin D3 compounds
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
US5210237A (en) * 1991-08-27 1993-05-11 Daikin Industries, Ltd. Vitamin d3 analogues
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
ES2091515T3 (es) * 1992-05-20 1996-11-01 Hoffmann La Roche Analogos fluorados de la vitamina d3.
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
TW267161B (xx) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger

Also Published As

Publication number Publication date
TW374762B (en) 1999-11-21
AR007240A1 (es) 1999-10-27
PL320131A1 (en) 1997-11-24
JP2858571B2 (ja) 1999-02-17
AU2357297A (en) 1997-11-27
HU9700927D0 (en) 1997-07-28
IL120842A0 (en) 1997-09-30
SG50831A1 (en) 1998-07-20
MA24345A1 (fr) 1998-07-01
ES2150719T3 (es) 2000-12-01
DE69702812T2 (de) 2001-01-25
NO971934L (no) 1997-11-24
KR970074763A (ko) 1997-12-10
UY24563A1 (es) 2000-12-29
US5888994A (en) 1999-03-30
JPH1045712A (ja) 1998-02-17
DE69702812D1 (de) 2000-09-21
YU19997A (sh) 1999-07-28
HUP9700927A3 (en) 1999-07-28
NO971934D0 (no) 1997-04-25
CO4840512A1 (es) 1999-09-27
EP0808831B1 (en) 2000-08-16
CN1081184C (zh) 2002-03-20
BR9703373A (pt) 1998-09-15
EP0808831A3 (en) 1999-02-03
TR199700418A3 (tr) 1997-12-21
KR100237523B1 (ko) 2000-01-15
CZ157997A3 (en) 1997-12-17
CA2204478A1 (en) 1997-11-23
HRP970274A2 (en) 1998-04-30
PT808831E (pt) 2000-12-29
AU720098B2 (en) 2000-05-25
ATE195514T1 (de) 2000-09-15
GR3034832T3 (en) 2001-02-28
NZ314838A (en) 1998-01-26
CN1169425A (zh) 1998-01-07
MX9703776A (es) 1998-06-30
TR199700418A2 (xx) 1997-12-21
HUP9700927A2 (hu) 1998-01-28
EP0808831A2 (en) 1997-11-26
CA2204478C (en) 2006-11-21
DK0808831T3 (da) 2001-01-02

Similar Documents

Publication Publication Date Title
ZA974336B (en) Vitamin D3 analogs.
ZA974334B (en) Fluorinated Vitamin D3 analogs.
HK1019873A1 (en) Illudin analogs useful as antitumor agents.
ZA200110487B (en) Vitamin D3 Analogs.
ZA9711567B (en) Compounds.
ZA97944B (en) N: 1 Transcoder.
ZA975861B (en) Bromotiacumicin compounds.
SG70010A1 (en) Fluorinated vitamin d3 analogs
ZA974052B (en) New benzothiazolinones.
ZA974332B (en) Fluorinated vitamin D3 analogs.
ZA974056B (en) New thiazolopyridines.
ZA969923B (en) Antioxidant.
ZA979404B (en) Aspirinate compounds.
GB9601685D0 (en) Fluorinated compounds
SG24096A1 (en) Fluorinated vitamin D3 derivative
ZA933357B (en) Vitamin D3 fluorinated analogs
ZA9610663B (en) Wetsuit.
ZA978284B (en) Staircases.
GR2001944Y (en) Kinesthisiometer -goniometer feet.
ZA978645B (en) Lighting equipment.
ZA986155B (en) (+)-norcisapride.
SI1023263T1 (en) Novel vitamin d analogues